Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of €130.45 billion as of December 5, 2025. Its market cap has increased by 26.31% in one year.

Market Cap

130.45B

Enterprise Value

142.77B

Revenue

24.79B

Ranking

n/a

PE Ratio

18.87

Stock Price

€103.90

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 130.45B, an increase of 66,978.41%. That is a compound annual growth rate of 21.17%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	129.28B	16.27%
Dec 31, 2024	111.19B	21.76%
Dec 29, 2023	91.32B	-9.36%
Dec 30, 2022	100.75B	25.80%
Dec 31, 2021	80.09B	34.14%
Dec 31, 2020	59.70B	-18.50%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	52.13B
Siemens Healthineers AG	47.59B
Bayer Aktiengesellschaft	32.98B
Fresenius SE & Co. KGaA	26.69B
Sartorius Aktiengesellschaft	15.79B
Fresenius Medical Care AG	11.50B
Carl Zeiss Meditec AG	3.77B
Fielmann Group AG	3.60B

Market Cap Rankings